The United Nations Interim Force in Lebanon (UNIFIL) has successfully completed the first end‑to‑end establishment trial of a walking blood bank, marking an important milestone in operational medical preparedness for UN peace operations. This is the first time a UN mission has exercised the complete walking blood bank workflow, from volunteer donor recruitment through medical screening, blood collection, labelling, and safe storage, all fully in line with established protocols.
The achievement comes against a demanding operational backdrop. Sustained conflict in the region could disrupt conventional blood supply chains on which missions rely. Routes may close without warning, deliveries can be delayed or prevented, and cold‑chain continuity might not always be assured. In such an environment, the assumption that blood products will reliably arrive through standard external channels at the moment of greatest need is no longer safe. Missions must therefore build internal resilience to close this critical gap.
The establishment trial represents a concrete step forward. It translated policy and planning into real‑world capability, demonstrating that the mission can execute the full walking blood bank process in a controlled, governance‑compliant manner before any clinical emergency arises. Central to this progress is the creation of a foundational donor registry - the operational backbone of any walking blood bank – within the Mission. With medically screened volunteers now identified and documented, the capability has moved from concept to deployable readiness.
All activities were conducted under UN medical governance frameworks, with donor counselling and informed consent, safeguards for donor welfare, and full traceability in accordance with UN blood policies and international haemovigilance principles. Medical screening, eligibility assessment, and laboratory blood typing were performed to international standards, including the establishment of Low‑Titer O Whole Blood pathways to support rapid, safer transfusion when there is no time to type a recipient.
At the heart of this milestone are people. Volunteer donors from within the mission stepped forward to be part of a life‑saving system, supported by a multidisciplinary medical team spanning clinical care, laboratory services, and coordination. Their professionalism, teamwork, and adherence to standard operating procedures ensured the success of the trial, and represents a collective effort to prepare, together, to save lives.
Early transfusion is one of the strongest determinants of survival in severe haemorrhage, where every minute matters. That standard is not met by chance. It depends on preparedness: trained teams, ready equipment, and rehearsed workflows. This establishment trial is exactly that kind of preparation.
A walking blood bank is a contingency capability designed for austere and high‑risk settings. It enables UN operations to mobilize pre‑screened volunteer donors from within their own personnel to provide whole blood when conventional supplies are not sufficient or at risk.
This milestone is a beginning, not a destination. UNIFIL will continue to build and strengthen its walking blood bank capability in the period ahead, as part of a broader UN peacekeeping commitment to ensuring that life‑saving medical support is available in the field, wherever and whenever it is needed.
The walking blood bank initiative is made possible through the support of the United Nations Peace and Development Trust Fund (UNPDF).